Capstone Therapeutics Corp
OTC:CAPS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Capstone Therapeutics Corp
OTC:CAPS
|
US |
|
Greenthesis SpA
MIL:GTH
|
IT |
|
Uniti Group Inc
NASDAQ:UNIT
|
US |
|
H
|
Hazoor Multi Projects Ltd
BSE:532467
|
IN |
|
Accelerated Technologies Holding Corp
OTC:ATHC
|
US |
|
P
|
PT Hatten Bali PT Tbk
IDX:WINE
|
ID |
|
PEC Ltd
SGX:IX2
|
SG |
|
K
|
Kyowa Kirin Co Ltd
DUS:KY4
|
JP |
|
Lechwerke AG
F:LEC
|
DE |
|
CeCors Inc
OTC:CEOS
|
CA |
|
Aroa Biosurgery Ltd
ASX:ARX
|
NZ |
|
B
|
Baijiayun Group Ltd
NASDAQ:RTC
|
CN |
|
California Style Palms Inc
OTC:CFPI
|
US |
|
C
|
Clearfield Inc
F:AP7
|
US |
|
Aecon Group Inc
TSX:ARE
|
CA |
|
M
|
Mail.ru Group Ltd
OTC:MLRYY
|
CY |
|
F
|
FL Entertainment NV
AEX:FLE
|
FR |
|
G
|
Go Metals Corp
CNSX:GOCO
|
CA |
Bankruptcy Probability
Capstone Therapeutics Corp's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Capstone Therapeutics Corp Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Capstone Therapeutics Corp
OTC:CAPS
|
3.9m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
470B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
239.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
183.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
139.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
86.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
69.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
55.4B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Capstone Therapeutics Corp's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Capstone Therapeutics Corp has total debt of 3.1m USD. This includes both short-term (0 USD) and long-term (3.1m USD) debt.
You can find a full breakdown on its Balance Sheet.
